EWTX Edgewise Therapeutics, Inc.

Fundamentals / CIK 0001710072 / USD

Edgewise Therapeutics, Inc. reported $1.78B in total assets and net income of $1.01B through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open EWTX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$0$0$0-$156.9MFY 2020 Net Income: -$17.12M2020FY 2021 Net Income: -$42.81M2021FY 2022 Net Income: -$67.64M2022FY 2023 Net Income: -$100.2M2023FY 2024 Net Income: -$133.8M2024FY 2025 Net Income: -$167.8M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $151.4M $127.0M $90.91M $54.03M $32.19M $14.98M
Total Operating Expenses $191.4M $158.8M $114.4M $71.66M $43.22M $17.19M
Operating Income -$191.4M -$158.8M -$114.4M -$71.66M -$43.22M -$17.19M
EBITDA -$189.3M -$156.8M -$112.8M -$71.29M -$42.94M -$17.01M
Interest Income $23.61M $25.02M $14.19M $4.02M $402K $69K
Income Before Tax -$167.8M -$133.8M -$100.2M -- -- --
Income Tax Expense $4.0K $3.0K $4.0K $0 $0 --
Net Income -$167.8M -$133.8M -$100.2M -$67.64M -$42.81M -$17.12M
Basic EPS -$1.63 -$1.45 -$1.57 -$1.26 -$1.14 -$23.17
Diluted EPS -$1.63 -$1.45 -$1.57 -$1.26 -$1.14 -$23.17
Basic Shares Outstanding 102.9M 92.4M 63.7M 53.6M 37.5M 739.0K
Diluted Shares Outstanding 102.9M 92.4M 63.7M 53.6M 37.5M 739.0K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $31.57M $47.55M $42.65M $43.59M $37.48M $33.56M $36.76M $36.37M
Total Operating Expenses $46.14M $61.94M $54.12M $55.98M $46.86M $42.61M $45.96M $45.54M
Operating Income -$46.14M -$61.94M -$54.12M -$55.98M -$46.86M -$42.61M -$45.96M -$45.54M
EBITDA -$45.64M -$61.44M -$53.58M -$55.45M -$46.36M -$42.11M -$45.45M -$44.96M
Interest Income $16.50M $4.62M $5.10M $5.76M $6.19M $6.50M $5.16M $5.88M
Income Before Tax $1.32B -- -- -- -$40.67M -- -- --
Income Tax Expense $155.3M -- -- -- -- -- -- --
Net Income $1.17B -$57.33M -$49.01M -$50.22M -$40.67M -$36.12M -$40.80M -$39.66M
Basic EPS $10.71 -$0.53 -$0.46 -- -$0.39 -$0.34 -$0.43 --
Diluted EPS $9.65 -$0.53 -$0.46 -- -$0.39 -$0.34 -$0.43 --
Basic Shares Outstanding 108.9M 107.7M 107.1M -- 105.5M 104.9M 95.1M --
Diluted Shares Outstanding 120.9M 107.7M 107.1M -- 105.5M 104.9M 95.1M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $61.15M $41.67M $86.10M $21.99M $15.57M $104.9M
Cash & Short-Term Investments $61.15M $41.67M $86.10M $21.99M $15.57M $104.9M
Total Current Assets $543.4M $475.5M $327.0M $357.0M $283.8M $129.6M
Property, Plant & Equipment, Net $7.83M $9.50M $10.44M $8.53M $912K $516K
Other Non-Current Assets -- $262K $348K $251K $548K $975K
Total Non-Current Assets $9.22M $11.33M $13.04M $10.10M $1.46M $1.49M
Total Assets $552.6M $486.8M $340.0M $367.1M $285.2M $131.1M
Accounts Payable $6.01M $5.58M $4.03M $6.11M $3.84M $1.58M
Total Current Liabilities $27.37M $23.86M $16.77M $16.59M $10.52M $4.34M
Other Non-Current Liabilities -- -- -- -- $329K --
Total Non-Current Liabilities $2.98M $3.74M $4.43M $3.80M $329K $0
Total Liabilities $30.35M $27.60M $21.20M $20.39M $10.85M $4.34M
Total Debt (incl. Leases) $3.99M $4.74M $5.41M $4.41M -- --
Common Stock $10K $9.0K $7.0K $6.0K $5.0K --
Retained Earnings -$546.4M -$378.6M -$244.8M -$144.6M -$76.96M -$34.15M
Accumulated Other Comp. Income $677K $420K $99K -$1.35M -$514K --
Total Stockholders' Equity $522.3M $459.2M $318.8M $346.7M $274.4M -$33.42M
Total Equity $522.3M $459.2M $318.8M $346.7M $274.4M -$33.42M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $68.68M $72.32M $33.21M $61.15M $46.00M $43.40M $49.92M $41.67M
Cash & Short-Term Investments $68.68M $72.32M $33.21M $61.15M $46.00M $43.40M $49.92M $41.67M
Total Current Assets $1.77B $471.5M $509.8M $543.4M $573.9M $603.3M $443.2M $475.5M
Property, Plant & Equipment, Net $6.33M $6.89M $7.40M $7.83M $8.13M $8.60M $8.99M $9.50M
Other Non-Current Assets -- -- -- -- -- -- $695K $262K
Total Non-Current Assets $7.55M $8.17M $8.73M $9.22M $9.57M $10.08M $11.21M $11.33M
Total Assets $1.78B $479.7M $518.5M $552.6M $583.5M $613.3M $454.4M $486.8M
Accounts Payable $9.64M $4.67M $7.29M $6.01M $6.16M $8.32M $8.79M $5.58M
Deferred Revenue (Current) $5.20M -- -- -- -- -- -- --
Total Current Liabilities $144.1M $29.04M $22.54M $27.37M $21.65M $20.90M $21.11M $23.86M
Deferred Revenue (Non-Current) $900K -- -- -- -- -- -- --
Other Non-Current Liabilities $888K -- -- -- -- -- -- --
Total Non-Current Liabilities $3.25M $2.57M $2.78M $2.98M $3.17M $3.37M $3.56M $3.74M
Total Liabilities $147.4M $31.61M $25.32M $30.35M $24.82M $24.26M $24.67M $27.60M
Total Debt (incl. Leases) $3.38M $3.59M $3.79M $3.99M $4.18M $4.37M $4.56M $4.74M
Common Stock $10K $10K $10K $10K $10K $10K $9.0K $9.0K
Retained Earnings $513.4M -$652.7M -$595.4M -$546.4M -$496.2M -$455.5M -$419.4M -$378.6M
Accumulated Other Comp. Income -$5.60M -$500K -$252K $677K $701K $204K $401K $420K
Total Stockholders' Equity $1.63B $448.1M $493.2M $522.3M $558.6M $589.1M $429.7M $459.2M
Total Equity $1.63B $448.1M $493.2M $522.3M $558.6M $589.1M $429.7M $459.2M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$167.8M -$133.8M -$100.2M -$67.64M -$42.81M -$17.12M
Depreciation & Amortization $2.08M $2.07M $1.55M $368K $272K $185K
Stock-Based Compensation $34.75M $24.71M $17.56M $10.92M $4.40M $354K
Change in Payables $272K $1.74M -$92K $47K $2.65M $521K
Operating Cash Flow -$143.8M -$109.0M -$91.95M -$52.63M -$33.51M -$14.63M
Capital Expenditure -$256K -$1.31M -$5.75M -$5.55M -$668K -$203K
Free Cash Flow -$144.1M -$110.3M -$97.69M -$58.18M -$34.17M -$14.84M
Purchases of Investments -$527.2M -$477.1M -$255.9M -$292.4M -$288.2M -$24.18M
Investing Cash Flow -$32.79M -$184.7M $102.9M -$70.58M -$242.2M -$24.38M
Common Stock Issued $187.4M $239.1M $52.62M $129.2M -- --
Financing Cash Flow $196.1M $249.3M $53.17M $129.6M $186.4M $120.3M
Net Change in Cash $19.48M -$44.43M $64.10M $6.43M -$89.35M $81.26M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income $1.17B -$57.33M -$49.01M -$50.22M -$40.67M -$36.12M -$40.80M -$39.66M
Depreciation & Amortization $500K $500K $537K $525K $500K $500K $513K $577K
Stock-Based Compensation $8.56M $9.36M $8.71M $9.88M $8.09M $7.73M $9.06M $7.74M
Change in Payables $6.60M $781K $1.45M -$303K -$2.13M -$151K $2.86M $92K
Operating Cash Flow -$78.29M -$42.47M -$42.54M -$38.59M -$34.78M -$32.58M -$37.87M -$26.96M
Capital Expenditure -$17K -$32K -$260K -$73K -$89K -$50K -$44K -$274K
Free Cash Flow -$78.31M -$42.50M -$42.80M -$38.66M -$34.87M -$32.63M -$37.91M -$27.23M
Purchases of Investments -$1.40B -$53.09M -$110.2M -$74.28M -$67.00M -$263.8M -$122.2M -$63.18M
Investing Cash Flow $59.67M $78.49M $2.43M $49.76M $35.72M -$162.2M $43.90M $20.92M
Common Stock Issued -- -- -- -- -- -- -- $0
Financing Cash Flow $14.98M $3.09M $12.17M $3.98M $1.66M $188.2M $2.22M $2.90M
Net Change in Cash -$3.64M $39.11M -$27.94M $15.14M $2.60M -$6.52M $8.26M -$3.14M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -32.1% -29.1% -31.4% -19.5% -15.6% --
Return on Assets (ROA) -30.4% -27.5% -29.5% -18.4% -15.0% -13.1%
Current Ratio 19.85x 19.93x 19.50x 21.53x 26.97x 29.86x
Quick Ratio 2.23x 1.75x 5.13x 1.33x 1.48x 24.16x
Debt to Equity 0.01x 0.01x 0.02x 0.01x -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) 61.8% -44.0% -35.7% -32.1% -28.1% -25.6% -34.0% -29.1%
Return on Assets (ROA) 56.7% -41.1% -33.9% -30.4% -26.9% -24.6% -32.1% -27.5%
Current Ratio 12.30x 16.24x 22.61x 19.85x 26.51x 28.87x 20.99x 19.93x
Quick Ratio 0.48x 2.49x 1.47x 2.23x 2.13x 2.08x 2.36x 1.75x
Debt to Equity 0.00x 0.01x 0.01x 0.01x 0.01x 0.01x 0.01x 0.01x
Source: SEC EDGAR CompanyFacts (CIK 0001710072) · from March 31, 2020 Data through September 30, 2026 · synced Nov 20, 2026, 05:16 UTC · Open in terminal